FUT11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.201400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.297200E-01
Normal-vs-Stage2
7.562200E-01
Normal-vs-Stage3
2.358600E-01
Normal-vs-Stage4
4.300600E-01
Stage1-vs-Stage2
5.950000E-01
Stage1-vs-Stage3
1.490550E-01
Stage1-vs-Stage4
2.316800E-01
Stage2-vs-Stage3
1.336000E-01
Stage2-vs-Stage4
2.268600E-01
Stage3-vs-Stage4
1.250000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.407800E-01
Normal-vs-AfricanAmerican
5.982600E-01
Normal-vs-Asian
7.684200E-01
Caucasian-vs-AfricanAmerican
4.260400E-01
Caucasian-vs-Asian
3.222200E-01
AfricanAmerican-vs-Asian
2.772800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.088800E-01
Normal-vs-Female
7.150000E-01
Male-vs-Female
3.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.105400E-01
Normal-vs-Age(41-60Yrs)
4.082600E-01
Normal-vs-Age(61-80Yrs)
9.709600E-01
Normal-vs-Age(81-100Yrs)
4.053400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.439200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.600800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.708000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.517700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.722400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.495180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.491600E-01
Normal-vs-Daily Drinker
4.359800E-01
Normal-vs-Weekly Drinker
7.585400E-01
Normal-vs-Occasional Drinker
6.999800E-01
Normal-vs-Social Drinker
4.040000E-01
Non Drinker-vs-Daily Drinker
2.053600E-01
Non Drinker-vs-Weekly Drinker
4.658400E-01
Non Drinker-vs-Occasional Drinker
3.635800E-01
Non Drinker-vs-Social Drinker
5.719800E-02
Daily Drinker-vs-Weekly Drinker
6.964200E-02
Daily Drinker-vs-Occasional Drinker
3.576400E-02
Daily Drinker-vs-Social Drinker
1.009680E-02
Weekly Drinker-vs-Occasional Drinker
9.386000E-01
Weekly Drinker-vs-Social Drinker
3.331400E-01
Occasional Drinker-vs-Social Drinker
3.133600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.771200E-01
Normal-vs-Grade 2
4.764000E-02
Normal-vs-Grade 3
7.810300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.861600E-02
Grade 1-vs-Grade 3
5.810400E-02
Grade 1-vs-Grade 4
2.771200E-01
Grade 2-vs-Grade 3
5.266800E-01
Grade 2-vs-Grade 4
4.764000E-02
Grade 3-vs-Grade 4
7.810300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.575600E-01
Normal-vs-NonDiabetic
9.214000E-01
Diabetic-vs-NonDiabetic
7.200800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.794400E-01
Normal-vs-NoPancreatitis
9.082600E-01
Pancreatitis-vs-NoPancreatitis
4.683000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.778200E-01
Normal-vs-N1
7.155600E-01
N0-vs-N1
1.807990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.079400E-01
Normal-vs-TP53-NonMutant
9.557200E-01
TP53-Mutant-vs-TP53-NonMutant
5.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
